GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » Quick Ratio

Synthetic MR AB (XSAT:SYNT) Quick Ratio : 4.52 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Synthetic MR AB's quick ratio for the quarter that ended in Dec. 2023 was 4.52.

Synthetic MR AB has a quick ratio of 4.52. It generally indicates good short-term financial strength.

The historical rank and industry rank for Synthetic MR AB's Quick Ratio or its related term are showing as below:

XSAT:SYNT' s Quick Ratio Range Over the Past 10 Years
Min: 3.22   Med: 3.99   Max: 8.7
Current: 4.52

During the past 12 years, Synthetic MR AB's highest Quick Ratio was 8.70. The lowest was 3.22. And the median was 3.99.

XSAT:SYNT's Quick Ratio is ranked better than
89.19% of 675 companies
in the Healthcare Providers & Services industry
Industry Median: 1.22 vs XSAT:SYNT: 4.52

Synthetic MR AB Quick Ratio Historical Data

The historical data trend for Synthetic MR AB's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB Quick Ratio Chart

Synthetic MR AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.80 3.79 3.28 5.58 4.52

Synthetic MR AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.58 5.54 5.21 5.22 4.52

Competitive Comparison of Synthetic MR AB's Quick Ratio

For the Health Information Services subindustry, Synthetic MR AB's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthetic MR AB's Quick Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's Quick Ratio falls into.



Synthetic MR AB Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Synthetic MR AB's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(118.362-0)/26.158
=4.52

Synthetic MR AB's Quick Ratio for the quarter that ended in Dec. 2023 is calculated as

Quick Ratio (Q: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(118.362-0)/26.158
=4.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synthetic MR AB  (XSAT:SYNT) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Synthetic MR AB Quick Ratio Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthetic MR AB (XSAT:SYNT) Business Description

Traded in Other Exchanges
N/A
Address
Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (XSAT:SYNT) Headlines

From GuruFocus

Insiders Are Investing in Syntel

By Kyle Ferguson Kyle Ferguson 04-27-2017

Syntel Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-08-2010

Syntel Named a Partner of the Year by Pivotal

By Marketwired Marketwired 09-25-2018

RM LAW Announces Investigation of Syntel, Inc.

By PRNewswire PRNewswire 07-26-2018

Interim CEO Invests in IT Company

By Jennifer Chiou Jennifer Chiou 12-07-2016

Syntel to Present at Investor Conference

By Marketwired Marketwired 05-29-2018

Syntel Inc. (SYNT) CEO and President Prashant Ranade sells 3,000 Shares

By GuruFocus Research GuruFocus Editor 12-17-2010

Syntel Inc. (SYNT) Chairman, 10% Owner Bharat Desai sells 2,610,000 Shares

By GuruFocus Research GuruFocus Editor 11-22-2010